Parallax Volatility Advisers, L.P. Horizon Therapeutics Public LTD CO Transaction History

Parallax Volatility Advisers, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $139,561 - $163,193	-1,410 Reduced 7.26%	18,019 $2.08 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $859,160 - $1 Million	8,918 Added 84.84%	19,429 $2 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $1.13 Million - $1.19 Million	10,511 New	10,511 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $669,095 - $961,512	11,356 New	11,356 $703,000
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $56,173 - $71,376	650 Added 46.2%	2,057 $216,000

Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $699,677 - $851,241	-7,099 Reduced 83.46%	1,407 $152,000
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $572,323 - $687,273	6,227 Added 273.23%	8,506 $932,000
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $619,548 - $689,089	-7,184 Reduced 75.92%	2,279 $213,000
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $477,884 - $635,228	6,653 Added 236.76%	9,463 $871,000
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $188,270 - $237,135	2,810 New	2,810 $206,000
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $28,073 - $35,359	-419 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $23,141 - $33,490	419 New	419 $33,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.